All In MedTech

Device Trial Radar · NCT02470494

The EarLens Contact Hearing Device (CHD) Spectrum Study

Last checked: Nov 20, 2026Latest source record: Jun 27, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

46

Actual

Start

Jun 2015

Primary completion

Jun 2016

Study completion Nov 2016

Sponsor

Lead sponsor
EarLens CorporationNot on our public-company list
Sponsor type
Industry
First posted
Jun 12, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The EarLens System is an assistive hearing device that is intended to provide amplification for the treatment of patients with sensorineural hearing impairment. The purpose of the proposed study (Extended Investigation under the Continued Access Policy) is to continue to allow access to the investigational medical device with the collection of device utility and clinic process-flow data while the marketing application is under review at the FDA.

Conditions

  • Hearing Loss, Sensorineural

Interventions

  • Sound amplification provided via the EarLens CHDDevice

    Subjects with mild to severe hearing impairment receiving sound amplification treatment with EarLens CHD.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Hearing Stability Using Unaided Air Conduction Thresholds.Time frame: Baseline and up to 90-day.

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • California Hearing and Balance Center

    La Jolla, California

  • Rodney Perkins Associates

    Menlo Park, California

  • Camino Ear Nose and Throat Clinic

    San Jose, California

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.